Literature DB >> 22821955

Relation of aortic calcification, wall thickness, and distensibility with severity of coronary artery disease: evaluation with coronary CT angiography.

Seonah Jang1, Hwan Seok Yong, Kyung Won Doo, Eun-Young Kang, Ok Hee Woo, Eun Jung Choi.   

Abstract

BACKGROUND: Three known risk factors for aortic atherosclerosis predict the severity of coronary artery disease (CAD): aortic calcification (AC), aortic wall thickness (AWT), and aortic distensibility (AD).
PURPOSE: To determine the relationship of AC, AWT, and AD with the severity of CAD.
MATERIAL AND METHODS: A total of 104 patients who underwent both coronary CT angiography (CCTA) and invasive coronary angiography were enrolled. The severity of CAD was assessed by three methods: the segment involvement score (SIS), the segment stenosis score (SSS), and the modified Gensini score (mG). We quantified AC using the Agatston method on low-dose ungated chest CT (LDCT). We measured AWT at the thickest portion of the descending thoracic aorta on CCTA. AD was calculated as the difference between the maximum and minimum areas of the ascending aorta and the pulse pressure. The relationships between the severity of CAD and the three aortic factors were assessed.
RESULTS: The AC and AWT of the thoracic aorta were significantly higher in the occlusive CAD (OCAD) group (1984.21 ± 2986.10 vs. 733.00 ± 1648.71, P = 0.01; 4.13 ± 1.48 vs. 3.40 ± 1.01, P = 0.22). Patients with OCAD had more than one epicardial coronary artery with >50% luminal stenosis. The AC (r = 0.453 with SIS; r = 0.454 with SSS; r = 0.427 with mG) and the AWT (r = 0.279 with SIS; r = 0.324 with SSS; r = 0.304 with mG) were significantly correlated with all three methods, and the AD was negatively correlated with the SIS (r = - 0.221, P < 0.05, respectively) in the unadjusted model. After adjustment for cardiovascular risk factors, only the correlations between AC and all three methods assessing CAD remained significant.
CONCLUSION: There are significant relationships between AC, AWT and AD and severity of CAD. In particular, AC measured on LDCT is the most consistent predictor of severity of CAD.

Entities:  

Mesh:

Year:  2012        PMID: 22821955     DOI: 10.1258/ar.2012.110604

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Correlation between Aortic Wall Thickness and Coronary Artery Disease by 64 Slice Multidetector Computed Tomography.

Authors:  Abolhassan Shakeri; Farnaz Hafez Quran; Reza Javadrashid; Mohammad Hossein Abdekarimi; Morteza Ghojazadeh; Mohammad Bassir Abolghassemi Fakhree
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

2.  Association of atherosclerosis in the descending thoracic aorta with coronary artery disease on multi detector row computed tomography coronary angiography in patients with suspected coronary artery disease.

Authors:  Cornelis J Roos; Agnieszka J Witkowska; Michiel A de Graaf; Caroline E Veltman; Victoria Delgado; Greetje J de Grooth; J Wouter Jukema; Jeroen J Bax; Arthur J Scholte
Journal:  Int J Cardiovasc Imaging       Date:  2013-07-27       Impact factor: 2.357

3.  Not at random location of atherosclerotic lesions in thoracic aorta and their prognostic significance in relation to the risk of cardiovascular events.

Authors:  Jarosław Wasilewski; Jan Głowacki; Lech Poloński
Journal:  Pol J Radiol       Date:  2013-04

4.  Analysis of elasticity characteristics of ascending aorta, descending aorta and pulmonary artery using 640 slice-volume CT.

Authors:  Fei Yang; Dawei Wang; Huaijun Liu; Xiaolong Zhu; Dianjun Zou; Xiaocan Wang; Zhenshun Hu; Mengmeng Ji; Shujun Cui; Yue Xiang Zhu; Jing Wen
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  Mechanisms of arterial remodeling: lessons from genetic diseases.

Authors:  Bernard J van Varik; Roger J M W Rennenberg; Chris P Reutelingsperger; Abraham A Kroon; Peter W de Leeuw; Leon J Schurgers
Journal:  Front Genet       Date:  2012-12-13       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.